Assessing “Best Evidence”: Issues in Grading the Quality of Studies for Systematic Reviews

作者: Kathleen N. Lohr , Timothy S. Carey

DOI: 10.1016/S1070-3241(16)30461-8

关键词:

摘要: Article-at-a-Glance Background Evidence-based medicine, clinical practice guidelines, quality and value of health services, science-based decision making are becoming mainstays the care sector. As part evidence-based movement, systematic reviews literature on questions increasingly common. Part structured approach to evaluating involves assessing individual studies included in reviews. Review To clarify issues this area, 1998 Agency for Health Care Policy Research commissioned a small project determine how its 12 Practice Centers were carrying out their (called evidence reports ). The number potential checklists, scales, similar tools grading methodology or relevance is large; reliability, validity, feasibility, utility these either unmeasured quite variable. Conclusions Numerous methodologic await definitive research answers, but meantime teams developing authoritative can take certain steps ensure that approaches articles meet applicable scientific standards. Clinicians, program administrators, policymakers then be confident overall strength study conclusions.

参考文章(33)
David Haber, Guide to clinical preventive services: a challenge to physician resourcefulness Clinical Gerontologist. ,vol. 12, pp. 17- 29 ,(1993) , 10.1300/J018V12N03_03
Peter J Neumann, Gillian D Sanders, Louise B Russell, Joanna E Siegel, Theodore G Ganiats, None, Cost-effectiveness in health and medicine Oxford University Press. ,(1996)
Julie E. Buring, Sherry L. Mayrent, Charles H. Hennekens, Epidemiology in Medicine ,(1987)
Amy C Justice, Mildred K Cho, Margaret A Winker, Jesse A Berlin, Drummond Rennie, Peer Investigators, PEER Investigators, Does Masking Author Identity Improve Peer Review Quality?: A Randomized Controlled Trial JAMA. ,vol. 280, pp. 240- 242 ,(1998) , 10.1001/JAMA.280.3.240
Susan van Rooyen, Fiona Godlee, Stephen Evans, Richard Smith, Nick Black, Effect of blinding and unmasking on the quality of peer review: A randomized trial JAMA. ,vol. 280, pp. 234- 237 ,(1998) , 10.1001/JAMA.280.3.234
Robert A. McNutt, The Effects of Blinding on the Quality of Peer Review JAMA. ,vol. 263, pp. 1371- 1376 ,(1990) , 10.1001/JAMA.1990.03440100079012
Alejandro R. Jadad, R.Andrew Moore, Dawn Carroll, Crispin Jenkinson, D.John M. Reynolds, David J. Gavaghan, Henry J. McQuay, Assessing the quality of reports of randomized clinical trials : is blinding necessary? Controlled Clinical Trials. ,vol. 17, pp. 1- 12 ,(1996) , 10.1016/0197-2456(95)00134-4
Allan S. Detsky, C.David Naylor, Keith O'Rourke, Allison J. McGeer, Kristan A. L'Abbé, Incorporating variations in the quality of individual randomized trials into meta-analysis Journal of Clinical Epidemiology. ,vol. 45, pp. 255- 265 ,(1992) , 10.1016/0895-4356(92)90085-2
Mildred K Cho, Lisa A Bero, Instruments for Assessing the Quality of Drug Studies Published in the Medical Literature JAMA: The Journal of the American Medical Association. ,vol. 272, pp. 101- 104 ,(1994) , 10.1001/JAMA.1994.03520020027007
Kenneth F Schulz, Iain Chalmers, Richard J Hayes, Douglas G Altman, Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials JAMA: The Journal of the American Medical Association. ,vol. 273, pp. 408- 412 ,(1995) , 10.1001/JAMA.273.5.408